What New Research Reveals About Diabetic Ketoacidosis in Type 1 and Type 2 Diabetes

Diabetic ketoacidosis (DKA) is a medical emergency that occurs when the body lacks sufficient insulin to regulate blood sugar. Without adequate insulin, cells cannot absorb glucose for energy. Instead, the body breaks down fat rapidly, producing ketones—acidic compounds that build up in the blood. This combination of high blood sugar, excessive ketones, and increased blood acidity can damage multiple organ systems and become life-threatening if not treated quickly.

While DKA is often associated with type 1 diabetes, it can also occur in people with type 2 diabetes, particularly during severe illness or stress. Some people experience DKA as their first sign of diabetes.

DKA occurs at notably higher rates in the Arab world compared to Western regions. This geographic difference suggests that factors beyond diabetes type—such as access to healthcare, insulin availability, disease awareness, and healthcare infrastructure—may influence how often people experience this dangerous condition. Research that examines DKA in different parts of the world helps doctors understand these patterns and improve care globally.

Researchers at Damascus University and Damascus Hospital conducted a retrospective analysis of hospital records to understand DKA better. They examined 533 hospital admissions for DKA, focusing on 263 first-time episodes. Among those first episodes, 126 patients (roughly 48%) had type 1 diabetes, while 71 patients (roughly 27%) were diagnosed with diabetes for the first time during their DKA event. This suggests that DKA can be a person's entry point into a diabetes diagnosis.

The study collected detailed information about each patient's demographics, hospitalization length, diabetes type, what may have triggered the DKA episode, and key blood chemistry measurements. This data provides a clearer picture of how DKA presents differently across individuals and diabetes types.

Understanding the biochemical differences between type 1 and type 2 diabetes patients who experience DKA is important for developing tailored treatment approaches. Not all cases of DKA look identical or require the same intervention strategy. By examining patterns in different populations—including those in regions where DKA is more common—researchers can help doctors recognize and treat DKA more effectively.

This research also highlights the value of studying diabetes complications in diverse healthcare settings. Insights from hospitals in Syria and other parts of the world contribute to a more complete understanding of how to manage DKA globally.

Source: BMC endocrine disorders. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.